The subject matter of the present application are pharmaceutical and/or cosmetic compositions which comprise at least one organic solvent in which complexes of at least one nucleic acid and organic cations are present in dissolved form. The compositions are advantageously suitable for use in the introduction of nucleic acid into cells and/or tissue, in particular of a mammal.
